PDS Biotechnology
PDSB
PDSB
51 hedge funds and large institutions have $19.2M invested in PDS Biotechnology in 2022 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 13 increasing their positions, 13 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
1.96% less ownership
Funds ownership: 20.58% → 18.62% (-2%)
47% less capital invested
Capital invested by funds: $36.2M → $19.2M (-$17M)
Holders
51
Holding in Top 10
–
Calls
$2.64M
Puts
$978K
Top Buyers
| 1 | +$710K | |
| 2 | +$549K | |
| 3 | +$173K | |
| 4 |
IWA
Inspirion Wealth Advisors
Libertyville,
Illinois
|
+$135K |
| 5 |
BlackRock
New York
|
+$133K |
Top Sellers
| 1 | -$1.75M | |
| 2 | -$1,000K | |
| 3 | -$737K | |
| 4 |
D.E. Shaw & Co
New York
|
-$514K |
| 5 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$436K |